Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results

Building Global Momentum for Interventions in Alzheimer's Disease - a Lausanne VIII Workshop Panel

Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access

Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference

Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result

Anavex Life Sciences to Announce Fiscal 2021 3rd Quarter Financial Results on Thurs., Aug. 12, 2021

Anavex Life Sciences to Participate in the BTIG Virtual Biotechnology Conference 2021

Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook

Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit

Anavex Life Sciences to Announce Fiscal 2021 2nd Quarter Financial Results and Business Outlook

Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference

Anavex Life Sciences to Present at the 20th Annual Needham Virtual Healthcare Conference

Anavex Life Sciences Announces Participation at World EPA – Evidence, Pricing and Access Congress

Anavex Life Sciences to Present at the H.C. Wainwright Global Life Sciences Conference

Anavex Life Sciences Announces Participation at Worldwide NIH Panel at Rare Disease Day®

Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit

Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook

Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook